Hackett Group (HCKT) Q2 2026 Earnings Call Transcript

The Hackett Group posted Q2 revenue before reimbursements of $68.3M (slightly below the low end of guidance) and adjusted EPS of $0.34 (midpoint of guidance), alongside GAAP net income of $4.4M. Management guided Q3 revenue before reimbursements to $68M–$70M and adjusted diluted EPS to $0.37–$0.39, citing a sequential gross margin improvement to 44.1% from 42.3% and AI-driven productivity gains. The company reported $30M of platform-led contract wins and continued shareholder returns (repurchased $4M of stock at $10.58/share and declared a $0.12 dividend), while also improving liquidity with operating cash flow of $15.2M and a reduced net debt position.

Analysis

The near-term winner is HCKT’s gross margin profile, not its top line. The market should focus on whether the company can convert a static revenue base into expanding operating leverage through fewer delivery hours, tighter staffing, and more software-adjacent implementation work; that is the only path to a higher multiple here. The flip side is that this is still a small-cap services business with AI packaging layered on top of discretionary IT spend, so a handful of large wins can improve optics without proving durable demand elasticity.

Competitive dynamics are changing in HCKT’s favor at the margin because enterprises increasingly want process validation and implementation help rather than generic “AI strategy.” That helps consultancies with proprietary workflow IP and hurts broad AI-first pitches from larger firms and pure software vendors that lack services depth. IBM’s pause is a warning that channel-led AI monetization remains fragile; if large partners prioritize their own go-to-market motions, HCKT’s pipeline could become more self-generated, which is higher-margin but also less scalable and less predictable.

The main catalyst path is over the next 1-3 months: the XT upgrade, partner starts, and proof that the new bookings convert into recognizable revenue rather than just a longer-dated pipeline. Over 6-18 months, the thesis depends on whether margin expansion can outrun what is likely still low-single-digit organic growth. Contrarian view: consensus may be overestimating AI as a demand driver and underestimating that current improvement may mostly be cost takeout plus mix shift; if utilization softens or software sales normalize, the model can reflate quickly in the other direction.

Key Decisions for Investors

• Tactical long HCKT only on post-earnings weakness or sub-$11.00 retracement; risk/reward is acceptable if management can hold Q3 gross margin guidance, but upside likely caps unless revenue inflects above the guidance range.
• Pair trade: long HCKT / short IBM for 1-3 months as a relative-value expression of smaller, faster productization versus a large vendor whose partner motions are deferred; thesis breaks if IBM reaccelerates partner-led AI messaging or HCKT loses its channel narrative.
• Watchlist alert: if HCKT fails to convert the Aug. 7 XT launch into visible incremental bookings by the next update, treat the AI re-rating as narrative-driven and fade rallies into strength.
• If you want cleaner exposure to enterprise AI implementation spend, prefer ORCL or SAP over HCKT for 6-18 months; HCKT has more operating leverage, but also materially higher execution risk and less recurring revenue quality.
• No options recommendation yet: implied upside from margin expansion is real, but the $30M win pool appears long-dated; wait for evidence that Q4/Q1 revenue step-ups are translatable before paying up for convexity.